FDA Inspection 1145211 — GREFI
The FDA completed an inspection of GREFI on Jun 14, 2021 in Ponce, PR. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Biologics.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jun 14, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Ponce, PR (United States)